🔎 Trials Near Me

Home › Atake sa Puso › Florida

Pag-aaral pangklinika para sa Atake sa Puso sa Florida

5 pag-aaral para sa Atake sa Puso ang naghahanap ng mga kalahok sa mga site sa Florida.

Mga Lungsod sa Florida

Opisyal na teksto ng pag-aaral (English)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • - Boca Raton Regional - Research Physicians Network Alliance, Boca Raton
  • Nova Clinical Research, LLC, Bradenton
  • South Florida Nephrology Group, PA, Coral Springs
  • at 14 pa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • Excel Medical Clinical Trials LLC, Boca Raton
  • Bay Area Cardiology Assoc, Brandon
  • Jacksonville Center for Clinical Research, Jacksonville
  • at 5 pa
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07517263

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • Excel Medical Clinical Trials, Boca Raton
  • Clearwater Cardiovascular Consultants, Clearwater
  • Jacksonville Center for Clinical Research, Jacksonville
  • at 14 pa
Nagre-recruitPhase 3
Edad 50 hanggang 105 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07136012

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

  • University of Florida - Gainesville, Gainesville
  • Tampa General Hospital, Tampa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT04774159

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

  • Abcentra Investigational Site, Boca Raton
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 27, 2026 · NCT06927739

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.